These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 26491894)

  • 21. PET/MRI: a new technology in the field of molecular imaging.
    Afaq A; Syed R; Bomanji J
    Br Med Bull; 2013; 108():159-71. PubMed ID: 24227824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG PET and PET/CT.
    Krause BJ; Schwarzenböck S; Souvatzoglou M
    Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.
    Spick C; Herrmann K; Czernin J
    J Nucl Med; 2016 Mar; 57(3):420-30. PubMed ID: 26742709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole body simultaneous PET/MRI: one-stop-shop?
    Maseeh-uz-Zaman ; Fatima N; Sajjad Z; Zaman U
    J Pak Med Assoc; 2014 Feb; 64(2):201-4. PubMed ID: 24640813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/MRI in children.
    Gatidis S; Bender B; Reimold M; Schäfer JF
    Eur J Radiol; 2017 Sep; 94():A64-A70. PubMed ID: 28131593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast PET/MRI Hybrid Imaging and Targeted Tracers.
    Romeo V; Helbich TH; Pinker K
    J Magn Reson Imaging; 2023 Feb; 57(2):370-386. PubMed ID: 36165348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET/MR - a rapidly growing technique of imaging in oncology and neurology.
    Sałyga A; Guzikowska-Ruszkowska I; Czepczyński R; Ruchała M
    Nucl Med Rev Cent East Eur; 2016; 19(1):37-41. PubMed ID: 26841378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/MRI for the body imager: abdominal and pelvic oncologic applications.
    Fraum TJ; Fowler KJ; McConathy J; Parent EE; Dehdashti F; Grigsby PW; Siegel BA
    Abdom Imaging; 2015 Aug; 40(6):1387-404. PubMed ID: 25805557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Workflow in Simultaneous PET/MRI.
    Barbosa Fde G; von Schulthess G; Veit-Haibach P
    Semin Nucl Med; 2015 Jul; 45(4):332-44. PubMed ID: 26050660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MR Imaging in Gynecologic Oncology.
    Ohliger MA; Hope TA; Chapman JS; Chen LM; Behr SC; Poder L
    Magn Reson Imaging Clin N Am; 2017 Aug; 25(3):667-684. PubMed ID: 28668166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET/MRI in Infection and Inflammation.
    Sollini M; Berchiolli R; Kirienko M; Rossi A; Glaudemans AWJM; Slart R; Erba PA
    Semin Nucl Med; 2018 May; 48(3):225-241. PubMed ID: 29626940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.